Crosslink Capital Makes its Biggest Bet Yet on Monday.com: Is the Stock a Buy?

Crosslink Capital increased its monday.com position by 143,650 shares in Q3, raising its holding to 203,865 shares valued at $39.49M as of Sept. 30, 2025 — a $20.55M quarter-over-quarter increase that represents 2.87% of the fund's $1.37B reportable U.S. equity AUM. Monday.com closed at $156.98 (Dec. 5, 2025), is down ~46% year-over-year, and reports TTM revenue of $1.2B and net income of $65M, with recent quarterly sales growth of 26% and a 117% net retention rate among large customers; valuation is roughly 24x free cash flow (48x including stock-based compensation). Crosslink's buy-the-dip accumulation and the company's AI-infused product positioning may draw investor interest, but the trade size relative to an $8.1B market cap and Crosslink's 22% quarter AUM reduction make broad market impact limited.

Analysis

Market structure: Crosslink’s third‑quarter accumulation of 143,650 MNDY shares is a modest but visible buy‑the‑dip signal; it nudges demand for a mid‑cap SaaS name that has seen 46% Y/Y price weakness, but the trade is unlikely to shift sector leadership alone. Direct winners are MNDY and cloud infra vendors (AWS/Azure) that host growing workload; competitors (ASAN, SMAR) face renewed pricing/feature competition as monday doubles down on AI‑infused modules. Supply/demand remains issuer‑driven — limited free float selling and concentrated buyer interest can amplify short‑term rallies, while Crosslink’s overall AUM cut (‑22%) limits sustained buying pressure.

Risk assessment: Key tail risks include accelerated commoditization of AI features reducing pricing power, rising stock‑based compensation (which doubles FCF multiple from ~24x to ~48x), and enterprise churn if macro softens; regulatory/privacy actions are low probability but high impact. Immediate horizon (days–weeks): headline‑driven volatility and IV spikes; short (1–6 months): execution on AI upsell and enterprise renewals; long (6–24 months): sustainable margin expansion depends on reducing SBC and sustaining net retention >110%. Hidden dependencies include a few large customers driving revenue concentration and Crosslink’s buying possibly reflecting opportunistic reallocation rather than conviction.

Trade implications: Tactical long exposure to MNDY is justified given 26% revenue growth and 117% net retention, but size it conservatively and hedge execution risk. Use defined‑risk option structures (12‑month call spreads) or pair trades versus ASAN/SMAR to isolate stock‑specific upside. Sector tilt: overweight AI‑enabled collaboration SaaS, underweight high‑SBC midsized SaaS until compensation trends normalize.

Contrarian angles: The market prizes headline FCF multiples but often underweights SBC dilution — the consensus “cheap at 24x FCF” may be overstated once SBC is capitalized. Crosslink’s purchase can be misread as full conviction; given their AUM shrinkage it could be tactical accumulation that will reverse if liquidity needs return. Historical parallels (post‑selloff SaaS rebounds) show large rebounds only after two quarters of margin improvement; absence of clear SBC reductions increases the probability of disappointing rallies.

Key Decisions for Investors

• Establish a staged long position in MNDY equal to 2% of portfolio at or below $165; add a second tranche (bringing total to ~3%) only if MNDY falls below $140. Set a price target of $220 within 9–12 months and a hard stop‑loss at $125 (≈20% below current price).
• Implement a defined‑risk options trade instead of naked equity: buy a Jan 2027 MNDY call spread (buy $140 / sell $220) allocating no more than 0.75% of portfolio notional to cap downside while capturing ~40%+ upside.
• Enter a relative‑value pair: long MNDY (1.0% notional) vs short ASAN (0.6% notional) for 3–6 months to hedge broad SaaS beta while expressing conviction in monday.com’s enterprise upsell (rebalance after next two quarterly reports).
• Monitor and act on stock‑based compensation and adjusted FCF signals: if MNDY’s SBC capitalized multiple remains >30x (i.e., adjusted FCF multiple ≥40–50x) after two consecutive quarters, reduce exposure by 50% — this is the primary valuation trigger to trim positions.